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Abstract 
The most intensive chemotherapy regimens
were used in the past for leukemia patients
who were the main focus of trials on infec-
tions; today there are increasing numbers of
children  with  solid  cancer  and  considerable
risk  of  infection  who  do  receive  intensive
stand  ard-dose  chemotherapy.  Despite  a  con-
tinuous  will  to  protect  the  immune-compro-
mised  child  from  infections,  evidence-based
indications for intervention by non-pharmaco-
logical  tools  is  still  lacking  in  the  pediatric
hematology-oncology literature. Guidelines on
standard precautions as well as precautions to
avoid  transmission  of  specific  infectious
agents are available. As a result of a consensus
discussion,  the  Italian  Association  for
Pediatric  Hematology-Oncology  (AIEOP)
Cooperative Group centers agree that for chil-
dren treated with chemotherapy both of these
approaches should be implemented and vigor-
ously  enforced,  while  additional  policies,
including  strict  environmental  isolation,
should be restricted to patients with selected
clinical conditions or complications. We pres-
ent here a study by the working group on infec-
tious diseases of AIEOP. 
Introduction
In the past the most intensive chemother  -
apy regimens were used for leukemia patients
who were the main subjects for trials on infec-
tions, and today there is an increasing number
of children with solid cancer who are at consid-
erable risk for infection and who receive inten-
sive standard-dose chemotherapy.1
The aim of non-pharmacological prophylax-
is  is  to  reduce  the  risk  of  transmission  of
infection to the patient as much as possible
while he/she is in the ward. This has been the
object of specific guidelines by the Centers for
Disease  Control  (CDC),  published  in  2007.2
However, these guidelines are general recom-
mendations for any hospital environment and
not specific for the immunocompromised host,
particularly  the  pediatric  oncology  patient.
Furthermore,  most  recommendations  are
based on uncontrolled studies or experts’ opin-
ions rather than on randomized controlled tri-
als,  and  they  frequently  refer  to  patients
undergoing  hematopoietic  stem  cell
transplant  ation (HSCT), while no specific rec-
ommendations are available for patients treat-
ed with chemotherapy alone.3
In an attempt to provide uniform criteria in
this field, the Italian Association for Pediatric
Hematology-Oncology  (AIEOP)  organized  a
consensus conference at which the issue was
debated. We present a paper by the working
group on infectious diseases of AIEOP, which
includes suggestions of standard precautions
for any patient (Table 1), and of solutions to
prevent specific transmission-based infections
(Table 2).2
Background knowledge 
Several host factors can increase suscepti-
bility to infection, including the following: a
variety of medications that alter the normal
flora  (e.g.  antimicrobial  agents,  gastric  acid
suppressants,  corticosteroids,  immune  sup-
pressive  drugs,  antineoplastic  agents,  and
immunosuppressive  drugs);  surgical  proced  -
ures and radiation therapy that impair defens-
es of the skin and other involved organ sys-
tems;  indwelling  devices  such  as  central
venous (or arterial) catheters, which facilitate
development of infections by allowing poten-
tial pathogens to bypass local defenses. This
would  ordinarily  impede  their  invasion,  and
provide surfaces for development of bio-films
that may facilitate adherence of microorgan-
isms and protect from antimicrobial activity.4-6
Children with cancer may have additional risk
factors  owing  to  their  age  and  age-related
behaviors:  an  increased  numbers  of  close
physical  contacts  between  them  and  health-
care personnel may occur because of cuddling,
feeding, playing, changing soiled diapers, and
cleaning  copious  uncontrolled  respiratory
secretions. This may provide abundant oppor-
tunities for transmission of infectious materi-
al. Practices and behaviors such as congrega-
tion of children in play areas where toys and
body secretions are easily shared, and family
members rooming in can further increase the
risk of transmission. Pathogenic bacteria have
been recovered from toys used by hospitalized
patients; contaminated bath toys were impli-
cated  in  an  outbreak  of  multidrug-resistant
Pseudomonas aeruginosa in a pediatric oncol  -
ogy unit.7 Pathogen outbreak is a major con-
cern in the healthcare setting, especially for
resistant  strains.2,3 Is  physical  isolation  a
response  to  this  worry?  A  randomized  trial
among  patients  with  acute  leukemia,  per-
formed  in  1978,  showed  a  decrease  in  fatal
infections  with  increased  survival  among
patients  treated  in  a  protected  environment
with prophylactic antibiotics.8 However, even
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in these early studies, the independent role of
isolation versus antibiotic prophylaxis was not
addressed,  and  the  recognition  of  emerging
antibiotic-resistant  strains  of  bacteria  when
using antibiotics for patient protection rapidly
became a worry.9 Thus, available knowledge in
this field is very limited and mostly derived
from experience in patients undergoing HSCT,
incorporating the use of laminar air flow (LAF)
units,  patient  isolation  units,  prophylactic
antibiotics, sterile and low-microbial diets, and
antimicrobial  decontamination.10-13 Even  in
this  setting,  early  prospective,  randomized
studies  of  protective  environments  among
HSCT recipients suggested that LAF isolation
and decontamination procedures resulted in a
significant reduction in infections, but in no
difference  in  survival,  with  most  deaths  a
result of interstitial pneumonia or recurrent
disease.10 A retrospective study of the use of
HEPA filtration units showed a reduction in
the number of Aspergillus organisms in the air
and  a  decrease  in  the  risk  of  nosocomial
Aspergillus infections.14
Current AIEOP standards 
The AIEOP cooperative group has been work-
ing in pediatric hematology-oncology for about
40  years.15 On  the  basis  of  the  growing
experiece in the treatment of children with can-
cer, constitutional or acquired bone marrow fail-
ure syndromes, or immune deficiencies, special
attention has been paid to all measures aimed
at reducing the risk for fatal infectious compli-
cations. Most of the effort has been aimed at
developing pharmacological protocols for treat-
ment or even prophylaxis of infections in the
immune compromised host.16 Cooperative pro-
tocols  and  guidelines  for  supportive  therapy
have  been  developed  mostly  as  part  of  the
chemotherapy treatment protocols. However, no
special recommendations have been developed
for non-pharmacological prophylaxis to date. As
a general rule, isolation of patients at higher
risk  for  infection,  and  in  particular  during
HSCT, has been applied. During the mid 1980s,
the use of LAF hoods became popular, especial-
ly  among  the  larger  centers.13 Otherwise,  no
specific regulations or recommendations have
been generated by the association. Thus, cur-
rent policies in the over 40 AIEOP centers are
based  on  local  experience  or  attitudes.  This
prompted the group to address the issue of the
opportunity to standardize the behaviors in the
participant centers. 
Measures aimed at protection 
of the patient
Overall, several issues have to be considered
when trying to define if and which measures of
non-pharmacological  methods  are  indicated
for prevention of infection in children under-
going chemotherapy. Available indications are
sparse,  mainly  derived  from  observation  of
patients  undergoing  transplants,  and  never
obtained  through  specific  studies  or  even
prospective data collection. Recommendations
have  focused  on  issues  of  ventilation,  con-
struction, room cleaning, isolation and barrier
precautions,  interactions  with  healthcare
workers and visitors, skin and oral care, infec-
tion  surveillance,  and  prevention  of  specific
nosocomial and seasonal infections. 
In an era of increasing financial constraints,
recommendations  on  specific  interventions
that may turn out to be expensive and time-
consuming need to be carefully revisited and,
whenever possible, validated. Regarding this
issue, it may be interesting to note that while
the CDC/IDSA/ASBMT guidelines contain over
200  recommendations  for  infection  control
among HSCT recipients, only seven are sup-
ported by level I (randomized trial) evidence.
Six recommendations hold clinical benefit and
one is associated with harm. These level I rec-
ommendations  do  not  include  the  use  of
patient  isolation  units,  ventilation  systems,
construction  or  cleaning  guidelines,  skin  or
oral care, or the prevention of catheter-associ-
ated infections. The first AI recommendation
(strongly recommended with randomized trial
support)  involves  the  long-held,  low-technol  -
ogy,  infection  control  practice  of  handwash-
ing.2 Guidelines for hand hygiene have been
published, which specifically address issues of
the indications for handwashing and antisep-
sis, the handwashing technique, surgical hand
antisepsis,  the  selection  of  hand  hygiene
agents, and even healthcare worker education-
al  and  motivational  programs.17 However,  a
cross-sectional  survey  of  university  hospital
physicians  showed  a  dismal  57%  average
adherence.18Concerning the handwashing pol-
icy, the problem is how to improve this attitude
and its compliance in the hospitals. Many stud-
ies  suggest  that  the  education  and  controls
must be continuous, to highlight the attention
of careworkers to this topic: easy, timely access
to both hand hygiene and skin protection is
necessary for satisfactory hand hygiene behav-
ior.  Alcohol-based  hand  rubs  may  be  better
than traditional handwashing as they require
less  time,  act  faster,  are  less  irritating,  and
contribute to sustained improvement in com-
pliance  associated  with  decreased  infection
rates.19 Whenever  possible,  local  surveys  on
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Table 1. Standard precautions.*
Handwashing (or using an antiseptic handrub)
• After touching blood, body fluids, secretions, excretions, and contaminated items
• Immediately after removing gloves
• Between patient contacts
Gloves
• For contact with blood, body fluids, secretions, and contaminated items
• For contact with mucous membranes and non-intact skin
Masks, goggles, face masks
• Protect mucous membranes of eyes, nose, and mouth when contact with blood and
body fluids is likely
Gowns
• Protect skin from blood or body fluid contact
• Prevent soiling of clothing during procedures that may involve contact with blood
or body fluids
Linen
• Handle soiled linen to prevent touching skin or mucous membranes
• Do not pre-rinse soiled linen in patient care areas
Patient care equipment
• Handle soiled equipment in a manner to prevent contact with skin or mucous
membranes and to prevent contamination of clothing or the environment
• Clean reusable equipment prior to reuse
Environmental cleaning
• Routinely care, clean, and disinfect equipment and furnishings in patient care areas
Sharps
• Avoid recapping used needles
• Avoid removing used needles from disposable syringes
• Avoid bending, breaking, or manipulating used needles by hand
• Place used sharps in puncture-resistant containers
Patient resuscitation
• Use mouthpieces, resuscitation bags, or other ventilation devices to avoid mouth-to-mouth
resuscitation
Patient placement 
• Place patients who contaminate the environment or cannot maintain appropriate hygiene in private
rooms
*Adapted from Ljungman et al., 2009.[Pediatric Reports 2011; 3:e9] [page 29]
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Table 2. Transmission-based precautions are used when the route(s) of transmission is(are) not completely interrupted using standard
precautions alone.*
Airborne precautions Droplet precautions Contact precautions
Used in addition to standard precautions Used in addition to standard Used in addition to standard precautions
for a patient known or suspected  precautions for a patient known for a patient known or suspected
to be infected with microorganisms  or suspected to be infected with to be infected or colonized with
transmitted by the airborne route microorganisms transmitted by  microorganisms transmitted by direct
large-particle droplets  contact with the patient or indirect
(larger than 5 μm) contact with environmental surfaces
or patient care items
Patient placement Patient placement Patient placement
Door closed Private room,  Private room,
Room air is exhausted to the outside  door may be left open door may be left open
(negative air pressure) using fan or other 
filtration system
If private room is not available, place patient  If private room is not available, If private room is not available,
in room with patient with active infection with  place patient in room with patient place patient in room with
the same disease, but with no other infection with active infection with the same disease, patient with active infection with
but with no other infection  the same microorganism, but with
If neither option is available, maintain  no other infection
separation  of at least 3 ft between patients
Respiratory protection Respiratory protection Contact  protection
If TB is known or suspected, wear particulate  Wear mask if within 3 ft of patient Gloving
respirator (if available) Wear clean, nonsterile examination gloves
If chickenpox or measles: for immune persons,  when entering room
no mask is required;  Change gloves after contact with infective material
susceptible persons, do not enter room  (e.g. fecal materials or wound drainage)
Remove PPE (face shield) after leaving the room  Remove gloves before leaving patient’s room
and place it in a plastic bag or waste  Handwashing
container with tight-fitting lid Wash hands with antibacterial agent or use 
alcohol-based handrub after removing gloves
Do not touch potentially contaminated surfaces or items
before leaving the room
Gowns and protective apparel
Wear clean, nonsterile gown when entering patient’s 
room if you anticipate contact with patient or if the 
patient is incontinent, has diarrhea, an ileostomy, 
colostomy, or wound drainage not contained 
by a dressing
Remove gown before leaving room. Do not allow clothing
to contact potentially contaminated surfaces or items 
before leaving room
Patient transport Patient transport Patient transport
Limit transport of patient to essential  Limit transport of patient to essential  Limit transport of patient to essential purposes only
purposes only. During transport, patient must  purposes only During transport, ensure precautions
wear surgical mask  During transport, patient must wear surgical are maintained to minimize risk 
Notify area receiving patient mask. Notify area receiving patient of transmission of organisms
Patient care equipment
Reserve noncritical patient care equipment for use with 
a single patient, if possible
Clean and disinfect any equipment shared among 
infected and noninfected patients
*Adapted from Ljungman et al., 2009.
Table 3. Empiric use of transmission-based precautions.*
Airborne Droplet  Contact
Rashes (vesicle or pustule) Severe, persistent cough during periods Acute diarrhea in an incontinent or diapered patient
Cough, fever, and upper lobe chest findings  when pertussis is present in community Diarrhea with history of recent antibiotic use
(dullness and decreased breath sounds)  Generalized rash of unknown cause Bronchitis and croup 
History of infection with multi-resistant organisms
Abscess or draining wound that cannot be covered
*Adapted from Ljungman et al., 2009.[page 30] [Pediatric Reports 2011; 3:e9]
the  compliance  promoted  by  the  hospital
authority may support the continuous applica-
tions  of  these  measures.  The  CDC/IDSA/
ASBMT  guidelines  address  an  additional  12
recommendations graded AII (strongly recom-
mended  with  well-designed  non-randomized
trial support). While the utility of specific iso-
lation and barrier precautions have not been
studied, a level AIII recommendation (strongly
recommended with expert opinion support) is
given to follow other published guidelines for
hospital isolation and the prevention of noso-
comial infections such as pneumonia or surgi-
cal site infections.2
Measures aimed at protection 
of contact persons, especially 
caregivers
All  suggestions  aimed  at  protecting  care-
givers are included in the universal precau-
tions section.
Contact with animals and avoiding food-
born infections
These issues were not addressed in the con-
sensus. 
Measures aimed at preventing transmission
of specific agents according to their route
of spread
A relevant issue may be the choice of which
strategy we may want to adopt to prevent dis-
semination of specific infections according to
their  usual  route  of  spread.  Thus,  additional
infection control recommendations can be con-
sidered  for  epidemiologic  factors  such  as  the
host,  human-to-human  interactions,  fomites,
air, food, water, soil, and construction and clean-
ing  (Table  2).  These  precautions,  which  are
aimed at limiting the spread of infectious agents
and  designed  for  avoiding  specific  infections,
should be applied empirically, according to the
clinical condition and the likely etiologic agents
at the time, and then modified when either the
pathogen is identified or a transmissible infec-
tious etiology is ruled out (Table 3). The clin  -
ician’s  experience  will  direct  specific  restric-
tions for patients for whom multidrug-resistant
bacterial strains or other potentially dangerous
exposure(s) may reasonably be suspected.
Conclusions
In conclusion, despite the general attitude
toward  children  undergoing  chemotherapy,
and particularly the practice of isolating them,
there may be a wide range of inter-center vari-
ability. Most likely, isolation of individual chil-
dren cannot be justified by currently available
data, unless they have specific complications
rather than uncomplicated fever of unknown
origin. The use of air filtering or other envir  -
onmental modifications, although possibly not
incorrect, cannot be considered as the desir-
able standard of care. On the contrary, stan-
dard procedures, such as those suggested by
CDC, appear warranted and definitely need to
be enforced. As a paradigm, repeated and care-
ful handwashing remains a pivotal behavior in
limiting  the  horizontal  spread  of  infectious
agents among children in a pediatric hematol-
ogy-oncology ward. As a result of the meeting,
the  expert  opinion  of  AIEOP’s  panel  recom-
mends using a combined approach of standard
and transmission-based precautions for chil-
dren  undergoing  chemotherapy  while  addi-
tional, more sophisticated and expensive envi-
ronmental procedures or structures cannot be
considered as mandatory.
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